THE STOCK HAS CLOSED SUCCESSFULLY ABOVE ALL MOVING AVERAGES, MAKING AN UPWARD CHANNEL. AT CMP IT IS A BUY FOR TARGET OF 210.
(***Bliss GVS Pharma Ltd's manufacturing facility (Unit-II) situated at Palghar, Maharashtra has successfully completed the re-audit as per EU-GMP guidelines by European authorities. This inspection was completed without any deficiencies.)
(***Bliss GVS Pharma Ltd's manufacturing facility (Unit-II) situated at Palghar, Maharashtra has successfully completed the re-audit as per EU-GMP guidelines by European authorities. This inspection was completed without any deficiencies.)
Komen:
TRADE ACTIVE BLISS GVS AT 194
Komen:
TARGET ACHIEVED @210